Article info

Download PDFPDF

Safety and efficacy of Edaravone Dexborneol versus edaravone for patients with acute ischaemic stroke: a phase II, multicentre, randomised, double-blind, multiple-dose, active-controlled clinical trial

Authors

  • Jie Xu Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China China National Clinical Research Center for Neurological Diseases, Beijing, China PubMed articlesGoogle scholar articles
  • Yilong Wang Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China China National Clinical Research Center for Neurological Diseases, Beijing, China PubMed articlesGoogle scholar articles
  • Anxin Wang Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China China National Clinical Research Center for Neurological Diseases, Beijing, China PubMed articlesGoogle scholar articles
  • Zhiqiang Gao Department of Neurology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, China PubMed articlesGoogle scholar articles
  • Xiaoping Gao Department of Neurology, The First Affiliated Hospital of Hunan Normal University, Changsha, China PubMed articlesGoogle scholar articles
  • Huisheng Chen Department of Neurology, General Hospital, PLA Shenyang Military Region, Shenyang, China PubMed articlesGoogle scholar articles
  • Junshan Zhou Department of Neurology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China PubMed articlesGoogle scholar articles
  • Xingquan Zhao Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China China National Clinical Research Center for Neurological Diseases, Beijing, China PubMed articlesGoogle scholar articles
  • Yongjun Wang Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China China National Clinical Research Center for Neurological Diseases, Beijing, China PubMed articlesGoogle scholar articles
  1. Correspondence to Prof. Xingquan Zhao; zxq{at}vip.163.com and Professor Yongjun Wang; yongjunwang{at}ncrcnd.org.cn
View Full Text

Citation

Xu J, Wang Y, Wang A, et al
Safety and efficacy of Edaravone Dexborneol versus edaravone for patients with acute ischaemic stroke: a phase II, multicentre, randomised, double-blind, multiple-dose, active-controlled clinical trial

Publication history

  • Received December 29, 2018
  • Revised February 20, 2019
  • Accepted February 25, 2019
  • First published April 22, 2019.
Online issue publication 
September 23, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.